13F Pro13F Pro

Geneos Wealth Management Inc.

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1764754
Institutional-grade research for retail investors

Sector Allocation

  • Other67.9%$3.3B
  • Technology9.5%$466.0M
  • Financials8.7%$428.0M
  • Industrials3.3%$162.3M
  • Healthcare2.5%$121.2M
  • Energy2.0%$96.7M
  • Consumer Discretionary1.7%$83.6M
  • Consumer Staples1.4%$70.4M
  • Real Estate0.9%$45.7M
  • Utilities0.9%$43.6M

AUM History

13fpro.ai/research/fund/geneos-wealth-management-inc-1764754

Conviction and streaks

Stable · top 10 = 19.1%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

Largest positions — Q2 2026

  • ISHARES
    $161.6M
  • SPYSPY
    $133.7M
  • ISHARES
    $115.5M
  • ISHARES
    $113.6M
  • VANGUARD
    $104.1M
  • ISHARES
    $71.6M
  • JANUS
    $66.1M
  • SPDR
    $59.4M
  • AAPLAAPL
    $58.9M
  • ISHARES
    $49.6M
  • NSCNSC
    $47.7M
  • NVDANVDA
    $46.0M
  • PUTNAM
    $44.8M
  • ISHARES
    $44.2M
  • SPDR
    $43.2M
  • QQQQQQ
    $42.3M
  • SPDR
    $39.7M
  • FIRST
    $38.7M
  • MSFTMSFT
    $37.2M
  • ISHARES
    $36.9M

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/geneos-wealth-management-inc-1764754

Geneos Wealth Management Inc. 13F holdings — Q2 2026

$4.9B portfolio (+13.7% QoQ) · 2,475 holdings · Q2 2026 13F · top 10 are 19% of the stock portfolio

  • 1

    ISHARES TR - CORE S&P500 ETF

    $161.6M

    3.3% of stocks

    +4%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • $133.7M

    2.7% of stocks

    -7%This quarter-0.4%Since filed5+ qtrsHeld
  • 3

    ISHARES TR - CORE S&P TTL STK

    $115.5M

    2.4% of stocks

    -4%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 4

    ISHARES TR - MSCI USA MIN VOL

    $113.6M

    2.3% of stocks

    +3%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 5

    VANGUARD INDEX FDS - S&P 500 ETF SHS

    $104.1M

    2.1% of stocks

    +25%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 6

    ISHARES TR - RUSSELL 3000 ETF

    $71.6M

    1.5% of stocks

    -2%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 7

    JANUS DETROIT STR TR - HENDRSN SHRT ETF

    $66.1M

    1.4% of stocks

    +2%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • 8

    SPDR SER TR - PORTFOLIO S&P500

    $59.4M

    1.2% of stocks

    -4%This quarter—Since filed—Held
    AIQuality—Est. buy—
  • $58.9M

    1.2% of stocks

    +7%This quarter+10.1%Since filed5+ qtrsHeld
  • 10

    ISHARES TR - 0-3 MNTH TREASRY

    $49.6M

    1.0% of stocks

    +80%This quarter—Since filed—Held
    AIQuality—Est. buy—

All holdings — Geneos Wealth Management Inc. (Q2 2026)

2,475 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated. The page lists up to 1,000; every position is in the Excel export.

Company
NSC$NSCNORFOLK SOUTHERN CORP$47.7M-0.6%
NVDA$NVDANVIDIA CORP$46.0M+22%
— PUTNAM ETF TRUST - FOCUSED LAR CAPetf/fund$44.8M+3%
— ISHARES TR - CORE MSCI TOTALetf/fund$44.2M+0.0%
— SPDR SER TR - PORTFOLI S&P1500etf/fund$43.2M+2%
QQQ$QQQINVESCO QQQ TRUST, SERIES 1etf/fund$42.3M-3%
— SPDR INDEX SHS FDS - PORTFOLIO DEVLPDetf/fund$39.7M+2%
— FIRST TR EXCHNG TRADED FD VI - TCW OPPORTUNIS$38.7M+4%
MSFT$MSFTMICROSOFT CORP$37.2M-1.0%
— ISHARES TR - CORE MSCI EAFEetf/fund$36.9M+0.2%
— SPDR SER TR - PRTFLO S&P500 GWetf/fund$36.1M+0.2%
— SPDR SER TR - PRTFLO S&P500 VLetf/fund$35.9M+0.0%
— VANGUARD BD INDEX FDS - INTERMED TERMetf/fund$35.7M+7%
— SCHWAB STRATEGIC TR - FUNDAMENTAL INTL$34.5M+5%
— VANGUARD TAX MANAGED FDS - VAN FTSE DEV MKTetf/fund$33.8M+4%

What changed in Q2 2026

Against the previous quarter's 13F: 80 new, 862 added to, 559 trimmed, 72 sold out. Share-count changes; largest moves by dollar size first.

New positions (80)

  • ISHARES INC - MSCI JPN ETF NEW$1.9M

    first bought this quarter

  • ISHARES INC - GLB ENR PROD ETF$638K

    first bought this quarter

  • DERM$DERMJourney Medical Corp$448K

    first bought this quarter

  • INNOVATOR ETFS TRUST - DEFINED WLT SHLD$283K

    first bought this quarter

  • VANECK ETF TRUST - REAL ASSETS ETF$267K

    first bought this quarter

  • ADVISORS INNER CIRCLE FD III - STRATEGAS MACRO$223K

    first bought this quarter

+74 more in the Excel export

Added to (862)

  • ISHARES TR - 0-3 MNTH TREASRY+80%

    now $49.6M

  • VANGUARD INDEX FDS - S&P 500 ETF SHS+25%

    now $104.1M

  • VANGUARD STAR FDS - VG TL INTL STK F+186%

    now $27.3M

  • VANGUARD INDEX FDS - GROWTH ETF+575%

    now $20.6M

  • NVDA$NVDANVIDIA CORP+22%

    now $46.0M · held 5+ qtrs

  • LMT$LMTLOCKHEED MARTIN CORP+786%

    now $8.1M · held 5+ qtrs

+856 more in the Excel export

Trimmed (559)

  • SPDR SER TR - BLOOMBERG 1-3 MO-52%

    now $10.8M

  • SPY$SPYSPDR S&P 500 ETF TRUST-7%

    now $133.7M · held 5+ qtrs

  • JCI$JCIJohnson Controls International plc-96%

    now $373K

  • XOM.R34088$XOM.R34088EXXON MOBIL CORP-30%

    now $17.4M · held 5+ qtrs, 4 trims in a row

  • NVS$NVSNOVARTIS AG-78%

    now $1.7M

  • BJ$BJBJ's Wholesale Club Holdings, Inc.-100%

    now $17K

+553 more in the Excel export

Sold out (72)

  • HON$HONHONEYWELL INTERNATIONAL INCwas $9.1M

    held 9+ qtrs

  • GLOBAL X FDSwas $2.1M
  • SPDR SER TRwas $2.1M
  • SA$SASEABRIDGE GOLD INCwas $1.1M

    held 9+ qtrs

  • VANECK ETF TRUSTwas $1.1M
  • SDA$SDASunCar Technology Group Inc.was $545K

+66 more in the Excel export

Firm AUM (Form ADV): $9.2B as of 2025-12-31 · SEC IAPD

Holdings by quarter

Every 13F Geneos Wealth Management Inc. has filed, 40 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Geneos Wealth Management?

Q2 2026 13F filed with the SEC on Aug 6, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Geneos Wealth Management's top 20 holdings: 72/100 (our AI quality score, weighted by position size; 17 of the 20 are scored)

Top 10 since filing

-1.5%

Value-weighted move of the 10 largest stock positions

Turnover

4%

Last quarter; 19% over the last 4

Top 10 weight

19%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

100%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q2 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Geneos Wealth Management Inc. disclosed 2,475 positions worth $4.9B in its Form 13F-HR for Q2 2026, followed by $SPY. During the quarter the fund opened 80 new positions and exited 72 and a full exit from $HON. The portfolio is most concentrated in Other (67.9% of disclosed assets). All figures are sourced directly from Geneos Wealth Management Inc.’s Form 13F-HR filing with the SEC under CIK 1764754.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Geneos Wealth Management Inc.

13F Pro is an AI hedge fund tracker and stock research platform. For Geneos Wealth Management Inc. (SEC CIK: 1764754), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Geneos Wealth Management Inc.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.